Pain Therapeutics, Inc. (PTIE)

JiminyBillyBob (87.65) Submitted: 2/25/08 3:57 AM : Start Price: $9.01 PTIE Score: 8.75

Tons of cash and no long term debt. While this company's prospects depend on future FDA approvals, it has enough of a cushion courtesy of King Pharmaceuticals in case things do not go as planned. Even risk-adverse investors should take a look at this stock because with the likely approval of Remoxy, the payoff is too great to ignore.

Report this Post Replies: 0 | Reply